Navigation Links
Senior Research Analyst Richard Evans Joins AVOS Life Sciences
Date:9/12/2007

MORRISVILLE, N.C., Sept. 12 /PRNewswire/ -- AVOS Life Sciences announced today that Richard Evans has joined AVOS as Vice President. His primary responsibility will be providing advisory services to companies in the prescription drug and biotech areas as well as selected investment assignments in capital markets. As an Institutional Investor (II) rated drug analyst, he will also have responsibility for AVOS' emerging portfolio of research products in the capital markets area.

"Richard brings us a senior level perspective on the drug industry," said Neil MacAllister, president of AVOS Life Sciences. "His background in capital markets complements our team and helps position AVOS as one of the strongest research and analysis firms in the pharmaceutical industry."

Mr. Evans has received several national awards from publications such as Bloomberg Markets magazine. He has been profiled in Barron's and Street.com. Richard has also provided financial commentary for The Wall Street Journal, The New York Times, CNBC, CNN, and NPR.

Mr. Evans earned a master's degree in Public and Private Management from Yale University. He is also a Doctor of Veterinary Medicine, having received his degree from North Carolina State University.

"One of AVOS' strengths," continued MacAllister, "is our first hand experience gained through extensive consulting engagements delivering strategic, operational and financial insight to healthcare and drug companies. Richard's expertise in analyzing financial market conditions will greatly add to AVOS' ability to deliver actionable recommendations to our clients by providing them with a full understanding of capital market reaction."

AVOS Life Sciences, LLC is a healthcare consulting and research firm located in Morrisville, North Carolina, and New York, New York. The company helps clients understand the rapidly evolving pharmaceutical, biotechnology, medical device and diagnostic market segments, thereby assisting with strategic business development and investment decisions. AVOS' analytical tools are structured to assist with real-time decision-making in a dynamic environment.

AVOS' proprietary approach includes knowledge obtained through coverage of leading industry events, access to internal and external healthcare databases and the analysis and perceptive commentary of a network of experts such as leading pharma executives, global regulatory specialists, manufacturing and reimbursement consultants, and a team of analytical scientists.

For more information on Richard Evans joining AVOS, please contact kgriffin@avoslifesciences.com

http://www.avoslifesciences.com


'/>"/>
SOURCE AVOS Life Sciences, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. SecurePipe appoints two senior execs
2. Third Wave announces two senior management appointments
3. Senior Wisconsin stem-cell researcher leaves for Connecticut
4. Sonic Foundry names new senior vice president
5. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
6. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
7. Control Your siRNA Research
8. Getting Started with MicroRNA Research
9. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
10. Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C
11. Research Organics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... The Pittcon Organizing Committee ... Chuck has been a volunteer member of Committee since 1987. Since then, he ... of directors and treasurer and was chairman for both the program and exposition committees. ...
(Date:4/27/2016)... SPRING, Md. and RESEARCH TRIANGLE ... Therapeutics Corporation (NASDAQ: UTHR ) announced today ... Executive Officer, of United Therapeutics will provide an overview ... Bank 41 st Annual Health Care Conference. ... 5, 2016, at 10:00 a.m. Eastern Time, and can ...
(Date:4/27/2016)... ... April 27, 2016 , ... PathSensors, Inc., a ... Board. Dr. Lamka will assist PathSensors in expanding the use of the company‚Äôs ... the CANARY® test platform for the detection of harmful pathogens, including a number ...
(Date:4/27/2016)... MIAMI (PRWEB) , ... April 27, 2016 , ... ... a mutual endorsement of an Asia-Pacific Symposium as other research and development initiatives for ... of Santiago officials and top Global Stem Cells Group executives began meeting to establish ...
Breaking Biology Technology:
(Date:3/14/2016)... 2016 NXTD ) ("NXT-ID" or the ... announces the airing of a new series of commercials on ... March 21 st .  The commercials will air on Bloomberg ... on the Street show. --> NXTD ) ("NXT-ID" ... commerce market, announces the airing of a new series of ...
(Date:3/10/2016)... 10, 2016 --> ... report "Identity and Access Management Market by Component (Provisioning, ... Governance), by Organization Size, by Deployment, by Vertical, and ... MarketsandMarkets, The market is estimated to grow from USD ... 2020, at a Compound Annual Growth Rate (CAGR) of ...
(Date:3/9/2016)... GARDENS, Fla. , March 9, 2016 /PRNewswire/ ... management authentication and enrollment solutions, today announced the ... DigitalPersona ® Altus multi-factor authentication platform. ... and InfoSec managers to step-up security where it,s ... Washington, DC . ...
Breaking Biology News(10 mins):